Ulcerative Colitis Clinical Trials
Ulcerative Colitis clinical trials study new biologics, small-molecule drugs, and treatment approaches for ulcerative Colitis and related immune or inflammatory conditions. Corterve gathers actively recruiting Ulcerative Colitis studies from ClinicalTrials.gov so you can browse by location and eligibility. This is general information, not medical advice — talk with your specialist before enrolling in a study.
Recruiting Ulcerative Colitis studies
- A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)NCT04844606PHASE3Eli Lilly and CompanyUlcerative ColitisSan Francisco, California
- Microbiome-targeted Diet Therapy in Ulcerative ColitisNCT07520461NAUniversity of MinnesotaUlcerative ColitisMinneapolis, Minnesota
- Family Members at INcreased-risk for Developing Inflammatory Bowel DiseaseNCT06655415Massachusetts General HospitalInflammatory Bowel Disease (IBD)Boston, Massachusetts
- A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative ColitisNCT07012395PHASE2Spyre Therapeutics, Inc.Ulcerative ColitisCanoga Park, California
- A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative ColitisNCT07158242PHASE3Hoffmann-La RocheModerately to Severely Active Ulcerative ColitisAurora, Colorado
- A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative ColitisNCT07071519PHASE3AbbVieUlcerative ColitisPhoenix, Arizona
- A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community SettingNCT06581328PHASE4TakedaUlcerative ColitisBirmingham, Alabama
- LY4268989 in Adults With Moderately to Severely Active Ulcerative ColitisNCT07415044PHASE2Eli Lilly and CompanyUlcerative Colitis (UC)Phoenix, Arizona
- Immune Regulation in Ulcerative Colitis or Crohn s DiseaseNCT00001184National Institute of Allergy and Infectious Diseases (NIAID)Inflammatory Bowel DiseaseBethesda, Maryland
- LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:NCT07186101PHASE2Eli Lilly and CompanyUlcerative ColitisScottsdale, Arizona
- Longitudinal Immunophenotyping of Patients With Inflammatory Bowel DiseaseNCT07619547National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Inflammatory Bowel DiseaseBethesda, Maryland
- Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b StudyNCT06937086PHASE3Eli Lilly and CompanyUlcerative ColitisDothan, Alabama
Ulcerative Colitis trials by state
Ulcerative Colitis trials by metro
Frequently asked questions
- How do I find recruiting Ulcerative Colitis clinical trials?
- Browse the actively recruiting Ulcerative Colitis studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
- Are Ulcerative Colitis clinical trials free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- Who can take part in a Ulcerative Colitis clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.